Chinese startup DeepSeek has released a new AI reasoning model that appears to rival the abilities of a frontier model from ...

Business Insider's diary takes you behind the scenes on day three of the World Economic Forum in Davos.

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

European artificial intelligence champion Mistral AI is “not for sale” and instead is working toward an initial public offering, according to Chief Executive Officer Arthur Mensch.

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with ...

The company fulfilled requests from Israel’s military for more access to AI tools, as it sought to compete with Amazon, ...

Mistral, the French AI lab, is working toward an initial public offering, co-founder and CEO Arthur Mensch said in an ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.